By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Roche 

Group Headquarters
Grenzacherstrasse 124
Basel    CH-4070  Switzerland
Phone: 41-61-688-11-11 Fax: 41-61-691-93-91


SEARCH JOBS

We have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.

YEAR FOUNDED:

1896

LEADERSHIP:

Founder: Fritz Hoffmann-La Roche

CEO: Severin Schwan

CFO: Alan Hippe

CLINICAL TRIAL:

Please click here for clinical trial information..

PRODUCTS:

US Product Portfolio.

JOB OPPORTUNITY:

www.roche.com/careers.

For more information, visit
www.roche.com and follow us on www.twitter.com/Roche.

FOLLOW ROCHE:





Key Statistics


Email:
Ownership: Public

Web Site: Roche
Employees:
Symbol: RHHBY
 





Collaborations

PanVera LLC 

GlaxoSmithKline (North Carolina) 

Gen-Probe Incorporated (Acquired by Hologic)  In February 2005, Gen-Probe signed a supply and purchase agreement with F. Hoffmann-La Roche Ltd. and its affiliate Roche Molecular Systems, Inc. under which Gen-Probe will purchase products for use in molecular diagnostic assays for human papillomavirus (HPV).

ArQule 

Entelos, Inc. 





Company News
New MagNA Pure 24 System By Roche (RHHBY) Offers Labs Improved Flexibility And Automation 3/17/2017 10:49:43 AM
Roche (RHHBY) Launches The Cobas EGFR Mutation Test V2 For Use With Either Plasma Or Tumor Tissue Samples 3/14/2017 8:48:21 AM
One Death in the HAVEN 1 Trial Complicates Roche (RHHBY)’s Entry into the Hemophilia A Market 3/13/2017 6:24:27 AM
Not Giving Up: Roche (RHHBY) To Start New Phase III Tests With Once-Failed Alzheimer's Drug 3/6/2017 8:55:34 AM
Roche (RHHBY)'s New Drugs May Protect Its Old Ones 3/3/2017 5:58:16 AM
Genentech (RHHBY) New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche (RHHBY) Stock Soars 3/2/2017 5:46:06 AM
Exelixis (EXEL) Announces Clinical Trial Collaboration With Roche (RHHBY) To Evaluate Cabozantinib And Atezolizumab In Locally Advanced Or Metastatic Solid Tumors 2/27/2017 6:46:37 AM
Roche (RHHBY)'s Renal Success Spells Danger For All-Comer Studies 2/27/2017 6:09:54 AM
Roche (RHHBY) Reports Death in Phase III Hemophilia Study 2/23/2017 5:33:21 AM
Bristol-Myers Squibb (BMY) Could Finally Go on the Market; Rumored Suitors Include Gilead (GILD), Pfizer (PFE), Novartis AG (NVS) and Roche (RHHBY) 2/14/2017 10:38:25 AM
12345678910...
//-->